Healthcare Third-Party Logistics (3PL) Market Size, Share & Trends Analysis Report By Product (Biopharmaceuticals, Pharmaceuticals, Medical Device), By Service (Transportation, Warehousing & Storage, Others), By Supply Chain (Cold Chain, Non-Cold Chain Logistics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Healthcare Third-Party Logistics (3PL) Market Size & Growth Analysis

The global healthcare third-party logistics market size was valued at USD 278.79 billion in 2025 and is projected to grow from USD 300.31 billion in 2026 to USD 544.43 billion by 2034, registering a CAGR of 7.72% during the forecast period from 2026 to 2034. North America dominated the healthcare third-party logistics market with a market share of 41.37% in 2025.

The healthcare third-party logistics (3PL) market refers to the outsourcing of logistics and supply chain operations by healthcare manufacturers, distributors, and suppliers to specialised service providers to ensure the efficient, compliant, and secure movement, storage, and distribution of healthcare products. The market, segmented by product, includes biopharmaceuticals, pharmaceuticals, comprising vaccines, biosimilars, plasma-derived products, and others and medical devices, categorised into Class I, II, and III. By service, it covers transportation (air freight, sea freight, and overland), warehousing & storage, and other value-added logistics functions such as packaging, labelling, and order fulfilment. By supply chain, it is divided into cold chain and non-cold chain logistics, supporting both temperature-sensitive products like biopharmaceuticals and vaccines, and general healthcare goods such as medical supplies and OTC products. Overall, healthcare 3PL providers play a critical role in enhancing supply chain efficiency, maintaining product integrity, ensuring regulatory compliance, and reducing operational costs across the global healthcare ecosystem.

Product Insights

The biopharmaceuticals segment dominated the market in 2025, with a 51.27% share, owing to the rising global demand for biologics, vaccines, and advanced therapies that require specialized handling, storage, and regulatory compliance. The increasing prevalence of chronic diseases and the expansion of pharmaceutical R&D activities have further fueled the demand for efficient biopharma logistics solutions.

The medical device segment is anticipated to register the fastest CAGR of 8.26%, owing to the growing distribution of complex and high-value medical equipment, advancements in medical technology, and the rising adoption of e-commerce and direct-to-hospital delivery models. Additionally, the increasing outsourcing of supply chain operations by device manufacturers to ensure cost efficiency and compliance with stringent safety regulations supports this segment’s growth.

Request Customizationto receive a tailored report.

Service Insights

The warehousing & storage segment dominated the market in 2025, with 48.16% share, due to the expansion of storage infrastructure equipped with advanced inventory management systems, temperature monitoring, and regulatory-compliant facilities for biopharmaceuticals and medical devices. The demand for safe, traceable, and efficient storage solutions has been amplified by rising product complexity and global distribution networks.

The transportation segment is anticipated to register the fastest CAGR of 9.07% during the forecast period, driven by the increasing demand for time-sensitive deliveries, growing adoption of digital freight platforms, and the integration of IoT and telematics for route optimization and real-time shipment tracking. Furthermore, the shift toward sustainable logistics through electric and hybrid vehicle adoption is accelerating segment expansion.

Supply Chain Insights

The non-cold chain logistics segment dominated the market growth due to the extensive demand for the transportation and distribution of pharmaceutical products, medical devices, and consumables that do not require temperature-controlled environments. This segment benefits from the growing volume of generic drugs, over-the-counter (OTC) products, and medical supplies, along with the increasing outsourcing of logistics services by healthcare manufacturers to enhance efficiency and reduce operational costs.

The cold chain segment is anticipated to register the fastest CAGR of 8.82%, owing to the increasing demand for temperature-controlled logistics solutions that ensure the safe storage and transportation of biopharmaceuticals, vaccines, and other temperature-sensitive healthcare products.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The North America region dominated the market with a revenue share of 41.37% in 2025, driven by advanced logistics infrastructure, strong regulatory compliance, and extensive outsourcing of distribution services by pharmaceutical companies. The region’s leadership is further supported by the widespread integration of digital logistics technologies such as warehouse automation, real-time temperature monitoring, and AI-driven supply chain analytics, which enhance efficiency and traceability across pharmaceutical and biotechnology shipments. These advancements have enabled healthcare organizations to manage large-scale vaccine distribution, biologics transport, and precision medicine logistics with greater speed and safety, reinforcing North America’s dominance in the global market.

In the U.S., market growth is primarily driven by the increasing adoption of value-added logistics solutions, including reverse logistics, cold chain packaging, and compliance consulting services tailored for the healthcare industry. The U.S. Food and Drug Administration’s (FDA) emphasis on Good Distribution Practices (GDP) compliance has encouraged healthcare manufacturers to partner with certified 3PL providers that offer secure, validated, and temperature-controlled transportation systems. This trend has enabled pharmaceutical companies to streamline distribution, reduce wastage, and ensure patient safety, thereby expanding the market growth.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

The Asia Pacific region is the fastest-growing market for healthcare 3PL, projected to register a CAGR of 9.26% during the forecast period. The rapid expansion is attributed to increasing pharmaceutical production in countries such as China, India, and South Korea, coupled with the modernization of healthcare logistics infrastructure. Government investments in smart logistics systems, automation, and cold chain network expansion are accelerating market growth. Moreover, the surge in biologics, vaccines, and clinical trial shipments across the region has intensified the demand for specialized, compliant 3PL services that ensure quality and product integrity throughout the supply chain.

In India, the healthcare 3PL market is growing rapidly due to the expansion of domestic pharmaceutical manufacturing and the government’s focus on enhancing healthcare distribution networks. Initiatives such as the National Logistics Policy (NLP) and the development of multi-modal logistics parks have improved transportation efficiency and reduced transit times for temperature-sensitive drugs. Additionally, partnerships between logistics providers and pharmaceutical firms are enabling end-to-end distribution solutions, from storage and packaging to last-mile delivery, strengthening India’s position as a major healthcare logistics hub in the Asia Pacific region.

Europe Market Insights

Europe holds a substantial share of the global healthcare 3PL market due to the region’s potent pharmaceutical manufacturing base and the rapid digital transformation of logistics networks. The implementation of the EU Falsified Medicines Directive (FMD) and the growing adoption of serialization and track and trace systems have accelerated the shift toward fully transparent and technology-integrated supply chains. Moreover, the rising focus on sustainable logistics practices such as green warehousing, carbon-neutral transport, and recyclable cold chain materials has further enhanced operational efficiency and compliance in pharmaceutical distribution across the continent.

In the United Kingdom, the healthcare 3PL market is being propelled by ongoing investments in digital logistics and the expansion of specialized distribution hubs. The increasing adoption of cloud-based logistics management systems and advanced automation tools has enabled more accurate inventory tracking and predictive demand forecasting. Additionally, the UK government’s focus on post-Brexit healthcare supply chain resilience has prompted logistics providers to establish regional facilities and improve cross-border efficiency, ensuring uninterrupted pharmaceutical flow and reinforcing the market’s stability and growth.

Middle East and Africa Market Insights

In the Middle East and Africa, market growth is primarily driven by increasing investment in cold chain infrastructure and the growing demand for temperature-controlled logistics solutions to support pharmaceutical imports and vaccine distribution. The expansion of healthcare systems, along with the region’s ongoing efforts to improve storage and distribution standards, has led to greater collaboration between governments and international logistics providers. Additionally, the introduction of digital tracking technologies and mobile-based supply chain monitoring platforms is enabling real-time visibility and improving the reliability of pharmaceutical delivery, even in remote and resource-limited areas.

In the UAE, the healthcare 3PL market is witnessing rapid development due to strategic government initiatives aimed at strengthening the nation’s role as a regional healthcare distribution hub. The Dubai Industrial Strategy and the establishment of logistics free zones dedicated to pharmaceutical warehousing have attracted leading global 3PL providers. Moreover, the integration of smart logistics solutions and AI-based warehouse management systems is supporting seamless operations for biologics and medical devices, positioning the UAE as a key logistics gateway for the broader Middle East and African markets.

Latin America Market Insights

In Latin America, the healthcare 3PL market is expanding steadily, supported by the localization of pharmaceutical distribution and the modernization of logistics infrastructure. Governments across Brazil, Mexico, and Argentina are encouraging private sector investment in healthcare warehousing, packaging, and cold chain transport to strengthen medicine availability and reduce supply delays. The growing adoption of digital logistics platforms for shipment tracking and inventory management has further enhanced operational transparency and regulatory compliance in the region.

In Brazil, the healthcare 3PL market is being driven by government initiatives promoting domestic pharmaceutical logistics and public-private partnerships aimed at improving supply chain efficiency. The National Health Surveillance Agency (ANVISA) has enforced stricter guidelines on drug traceability, prompting logistics providers to adopt serialization and electronic tracking systems. Furthermore, Brazil’s focus on expanding regional distribution centers has improved the accessibility of essential medicines across remote regions, thereby strengthening its role as a central logistics hub in Latin America’s healthcare ecosystem.

Competitive Landscape

The global healthcare third-party logistics (3PL) market is fragmented, with a combination of established logistics giants and emerging specialized providers driving competition. Major players such as DHL Supply Chain, UPS Healthcare, FedEx Supply Chain, Kuehne + Nagel, DB Schenker, and others dominate through global distribution networks, advanced cold-chain infrastructure, and regulatory compliance expertise. Additionally, emerging companies such as Kinesis Medical, Agility Logistics, and Kerry Logistics are gaining traction by offering innovative temperature-controlled solutions, clinical trial logistics, and region-specific services, strengthening their presence in the healthcare 3PL market.

Kinesis Medical B.V.: An emerging market player

Kinesis Medical, a specialized healthcare logistics provider, is emerging as a key player in the Healthcare Third-Party Logistics market with a focus on temperature-sensitive and clinical trial logistics. The company leverages advanced cold-chain technologies and real-time tracking systems to ensure the safe and compliant transportation of pharmaceuticals and biologics.

• In 2024, Kinesis Medical, expanded its European operations by opening a state-of-the-art temperature-controlled distribution center, enhancing its capacity to serve clinical trials and specialized pharmaceutical shipments. Through innovation and regional expansion, Kinesis Medical is establishing itself as a prominent emerging player in the healthcare 3PL market.

List of Key and Emerging Players in Healthcare Third-Party Logistics (3PL) Market